|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2-Nitronaphthalene |
CAS 581-89-5 | ||
C10H7NO2 |
RTECS QJ9760000 | ||
|
Synonyms & Trade Names beta-Nitronaphthalene |
DOT ID & Guide 2538 133 |
||
Exposure
|
NIOSH REL: Ca* See Appendix A [*Note: Since metabolized to beta-Naphthylamine.] | ||
| OSHA PEL: none | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
|
Physical Description Colorless solid. |
|||
|
MW: 178.2 |
BP: ? |
MLT: 174°F |
Sol: Insoluble |
|
VP: ? |
IP: 8.67 eV |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities For "Nitrates" in general: Aluminum, cyanides, esters, phosphorus, tin chlorides, thiocyanates, sodium hypophosphite |
|||
|
Measurement Methods None available See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation skin, respiratory system; dermatitis; [potential occupational carcinogen] | |
|
Target Organs
Skin, respiratory system Cancer Site [bladder cancer] |
|
| See also: INTRODUCTION |